Impact of COVID-19 Lockdown on Glucemic Control in Children and Adolescents with Type 1 Diabetes Mellitus in Cuba

Authors

Keywords:

confinement, COVID-19, type 1 diabetes mellitus, glycemic control.

Abstract

Introduction: Good glycemic control in pediatric patients with diabetes mellitus is essential to reduce the risk of complications and strengthen the immune system. COVID-19 pandemic lockdown may have impacted it. Objective: To determine the impact, in Cuba, of COVID-19 lockdown on glucemic control in children and adolescents with type 1 diabetes mellitus. Methods: An observational and prospective study was carried out in 41 patients under 19 years of age, with type 1 diabetes mellitus, in Ciego de Ávila province. These subjects were in lockdown from November 2020 to May 2021. The data were obtained from the medical records. Glucose level control was determined from the level of glycated hemoglobin and blood glucose. Results: Before lockdown, only 28 patients (68.1%) had glycated hemoglobin values higher than 7%, while during the study period, higher prevalence of patients with poor glycemic control was observed (78.05%). The requirements for higher total insulin doses (p = 0.005), the higher dosage per kilogram of weight (p = 0.003) and the longer evolution time (p = 0.011) were significantly related to poor glycemic control. Conclusions: Confinement negatively impacted on the glycemic control of children and adolescents with type 1 diabetes mellitus, since patients required higher insulin doses, and the average levels of glycated hemoglobin and fasting blood glucose were higher.

Downloads

Download data is not yet available.

References

1. Organización Mundial de la Salud. Cronología de la respuesta de la OMS a la COVID-19‎; 2021 [acceso 28/01/2024]. Disponible en: https://www.who.int/es/news/item/29-06-2020-covidtimeline

2. Shi L, Lu ZA, Que JY, Huang XL, Liu L, Ran MS, et al. Prevalence of and Risk Factors Associated with Mental Health Symptoms among the General Population in China during the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020;3(7). DOI: https://doi.org/10.1001/jamanetworkopen.2020.14053

3. Meaklim H, Junge MF, Varma P, Finck WA, Jackson ML. Pre-existing and post-pandemic insomnia symptoms are associated with high levels of stress, anxiety, and depression globally during the COVID-19 pandemic. J Clin Sleep Med. 2021;17(10):2085-97. DOI: https://doi.org/10.5664/jcsm.9354

4. Caycho-Rodríguez T, Vilca LW, Corrales-Reyes IE, Hernández-García F, Pérez AP, Quintana PG, et al. COVID-19 contagion concern scale (PRE-COVID-19): Validation in Cuban patients with type 2 diabetes. Diabetes Metab Syndr. 2021;15(5). DOI: https://doi.org/10.1016/j.dsx.2021.102245

5. Caycho-Rodríguez T, Valencia PD, Vilca LW, Corrales-Reyes IE, Hernández-García F, Pupo Pérez A, et al. Sociodemographic and Health Predictors of Concern about COVID-19 Infection in Cuban Patients with Type 2 Diabetes Mellitus. Electronic J General Medicine. 2022;19(2). DOI: https://doi.org/10.29333/ejgm/11620

6. Henríquez M, Ramírez-Campillo R, Cristi-Montero C, Reina R, Alvarez C, Ferrari G, et al. Alarming low physical activity levels in Chilean adults with disabilities during COVID-19 pandemic: a representative national survey analysis. Front Public Health. 2023;11. DOI: https://doi.org/10.3389/fpubh.2023.1090050

7. Mondaca MI, Garrido SS, Orellana TR, Roa AM, Quezada CO, Osorio-Fuentealba C. COVID-19 lockdown effects on the anthropometrics, aerobic capacity, muscle function and metabolic control in children and adolescents with overweight and obesity. J Pediatr (Rio J). 2023;99(5):471-7. DOI: https://doi.org/10.1016/j.jped.2023.03.008

8. Chen Y, Yang D, Cheng B, Chen J, Peng A, Yang C, et al. Clinical Characteristics and Outcomes of Patients with Diabetes and COVID-19 in Association with Glucose-Lowering Medication. Diabetes Care. 2020;43(7):1399-407. DOI: https://doi.org/10.2337/dc20-0660

9. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14(4):303-10. DOI: https://doi.org/10.1016/j.dsx.2020.04.004

10. Rico-Mesa JS, White A, Anderson AS. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB. Current Cardiol Rep. 2020;22(5). DOI: https://doi.org/10.1007/s11886-020-01291-4

11. Ogle GD, Wang F, Gregory GA, Maniam J. IDF Atlas reports. Type 1 diabetes estimates in children and adults. Brussels, Belgium: International Diabetes Federation; 2022 [acceso 28/01/2024]. Disponible en: https://diabetesatlas.org/idfawp/resource-files/2022/12/IDF-T1D-Index-Report.pdf

12. Carvajal F, García J, Araujo O, Hernández JR, Navarrete J, Pereira I, et al. COVID 19 y Diabetes Mellitus tipo 1 en la infancia, Cuba. Informe preliminar. Ciencia y Salud. 2022;6(1):25-33. DOI: https://doi.org/10.22206/cysa.2022.v6i1

13. Cianfarani S, Pampanini V. The Impact of Stress on Health in Childhood and Adolescence in the Era of the COVID-19 Pandemic. Horm Res Paediatr. 2023;96(1):83-7. DOI: https://doi.org/10.1159/000517460

14. García Ron A, Cuéllar-Flores I. Impacto psicológico del confinamiento en la población infantil y como mitigar sus efectos: revisión rápida de la evidencia. An Pediatr (Engl Ed). 2020;93(1):57-8. DOI: https://doi.org/10.1016/j.anpede.2020.04.008

15. Elhenawy YI, Eltonbary KY. Glycemic control among children and adolescents with type 1 diabetes during COVID-19 pandemic in Egypt: a pilot study. Int J Diabetes Dev Ctries. 2021;41(3):389-95. DOI: https://doi.org/10.1007/s13410-021-00968-y

16. Tornese G, Ceconi V, Monasta L, Carletti C, Faleschini E, Barbi E. Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Lockdown and the Role of In-Home Physical Activity. Diabetes Technol Ther. 2020;22(6):462-7. DOI: https://doi.org/10.1089/dia.2020.0169

17. Sánchez M, González de Buitrago J, Tejado ML, de Nicolás Jiménez JM. Repercusión del confinamiento por COVID-19 sobre el control glucémico en niños y adolescentes con diabetes mellitus tipo 1. An Pediatr (Engl Ed). 2022;97(1):22-9. DOI: https://doi.org/10.1016/j.anpedi.2020.12.021

18. World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human subjects. JAMA. 2013;310(20):1-95. DOI: https://doi.org/10.1001/jama.2013.281053

19. Capaldo B, Annuzzi G, Creanza A, Giglio C, De Angelis R, Lupoli R, et al. Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes. Diabetes Care. 2020;43(8). DOI: https://doi.org/10.2337/dc20-1127

20. Christoforidis A, Kavoura E, Nemtsa A, Pappa K, Dimitriadou M. Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system. Diabetes Res Clin Pract. 2020;166. DOI: https://doi.org/10.1016/j.diabres.2020.108307

21. Silverii GA, Delli Poggi C, Dicembrini I, Monami M, Mannucci E. Glucose control in diabetes during home lockdown for the first pandemic wave of COVID-19: a meta-analysis of observational studies. Acta Diabetol. 2021;58(12):1603-11. DOI: https://doi.org/10.1007/s00592-021-01754-2

22. Rabbone I, Schiaffini R, Cherubini V, Maffeis C, Scaramuzza A, Bertelli E, et al. Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children? Diabetes Care. 2020;43(11):2870-2. DOI: https://doi.org/10.2337/dc20-1321

23. Di Dalmazi G, Maltoni G, Bongiorno C, Tucci L, Di Natale V, Moscatiello S, et al. Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study. BMJ Open Diabetes Res Care. 2020;8(2). DOI: https://doi.org/10.1136/bmjdrc-2020-001664

Downloads

Published

2024-11-15

How to Cite

1.
Hernández García F, González-Velázquez VE, Pérez García ER, Pedraza Rodríguez EM, Casanovas Figueroa J. Impact of COVID-19 Lockdown on Glucemic Control in Children and Adolescents with Type 1 Diabetes Mellitus in Cuba. Rev Cubana Pediatría [Internet]. 2024 Nov. 15 [cited 2025 Oct. 9];96. Available from: https://revpediatria.sld.cu/index.php/ped/article/view/5579

Issue

Vol. 96 (2024): Publicación continua

Section

PEDIATRÍA

License

Avisos de derechos de autor propuestos por Creative Commons

1. Política propuesta para revistas que ofrecen acceso abierto

Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:

  1. Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
  2. Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
  3. Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).